The anti-tumour activity of DNA methylation inhibitor 5-aza-2'-deoxycytidine is enhanced by the common analgesic paracetamol through induction of oxidative stress.

MLA

Gleneadie, Hannah J., et al. “The Anti-Tumour Activity of DNA Methylation Inhibitor 5-Aza-2’-Deoxycytidine Is Enhanced by the Common Analgesic Paracetamol through Induction of Oxidative Stress.” Cancer Letters, vol. 501, Mar. 2021, pp. 172–86. EBSCOhost, https://doi.org/10.1016/j.canlet.2020.12.029.

APA

Gleneadie, H. J., Baker, A. H., Batis, N., Bryant, J., Jiang, Y., Clokie, S. J. H., Mehanna, H., Garcia, P., Gendoo, D. M. A., Roberts, S., Burley, M., Molinolo, A. A., Gutkind, J. S., Scheven, B. A., Cooper, P. R., Parish, J. L., Khanim, F. L., & Wiench, M. (2021). The anti-tumour activity of DNA methylation inhibitor 5-aza-2’-deoxycytidine is enhanced by the common analgesic paracetamol through induction of oxidative stress. Cancer Letters, 501, 172–186. https://doi.org/10.1016/j.canlet.2020.12.029

Chicago

Gleneadie, Hannah J, Amy H Baker, Nikolaos Batis, Jennifer Bryant, Yao Jiang, Samuel J H Clokie, Hisham Mehanna, et al. 2021. “The Anti-Tumour Activity of DNA Methylation Inhibitor 5-Aza-2’-Deoxycytidine Is Enhanced by the Common Analgesic Paracetamol through Induction of Oxidative Stress.” Cancer Letters 501 (March): 172–86. doi:10.1016/j.canlet.2020.12.029.